{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:01:41Z","timestamp":1771063301167,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32172909"],"award-info":[{"award-number":["32172909"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2024A1515010365"],"award-info":[{"award-number":["2024A1515010365"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangzhou Science and Technology Plan Project","award":["2024A04J3412"],"award-info":[{"award-number":["2024A04J3412"]}]},{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32121004"],"award-info":[{"award-number":["32121004"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"DOI":"10.1186\/s12917-025-04974-8","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:08:04Z","timestamp":1756458484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In vivo pharmacokinetic and pharmacodynamic profiles of orbifloxacin against Staphylococcus aureus in a neutropenic murine thigh infection model"],"prefix":"10.1186","volume":"21","author":[{"given":"Long-Gen","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Jia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu-Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Wen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"12","key":"4974_CR1","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1473-3099(05)70295-4","volume":"5","author":"HF Wertheim","year":"2005","unstructured":"Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5(12):751\u201362.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"4974_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro2200","volume":"7","author":"HF Chambers","year":"2009","unstructured":"Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7(9):629\u201341.","journal-title":"Nat Rev Microbiol"},{"key":"4974_CR3","doi-asserted-by":"publisher","first-page":"18033","DOI":"10.1038\/nrdp.2018.33","volume":"4","author":"AS Lee","year":"2018","unstructured":"Lee AS, de Lencastre H, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A, Harbarth S. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers. 2018;4:18033.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"4974_CR4","doi-asserted-by":"publisher","first-page":"e0228509","DOI":"10.1371\/journal.pone.0228509","volume":"15","author":"N D\u2019Atanasio","year":"2020","unstructured":"D\u2019Atanasio N, Capezzone de Joannon A, Di Sante L, Mangano G, Ombrato R, Vitiello M, Bartella C, Magar\u00f2 G, Prati F, Milanese C, et al. Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors. PLoS One. 2020;15(2):e0228509.","journal-title":"PLoS One"},{"issue":"9","key":"4974_CR5","first-page":"2741","volume":"61","author":"DE King","year":"2000","unstructured":"King DE, Malone R, Lilley SH. New classification and update on the quinolone antibiotics. Am Fam Physician. 2000;61(9):2741\u20138.","journal-title":"Am Fam Physician"},{"issue":"1","key":"4974_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.rvsc.2004.02.002","volume":"77","author":"JP Gani\u00e8re","year":"2004","unstructured":"Gani\u00e8re JP, M\u00e9daille C, Etor\u00e9 F. In vitro antimicrobial activity of Orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections. Res Vet Sci. 2004;77(1):67\u201371.","journal-title":"Res Vet Sci"},{"issue":"1","key":"4974_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1751-0147-54-16","volume":"54","author":"K Harada","year":"2012","unstructured":"Harada K, Shimizu T, Kataoka Y, Takahashi T. Post-antibiotic effect of Orbifloxacin against Escherichia coli and Pseudomonas aeruginosa isolates from dogs. Acta Vet Scand. 2012;54(1):16.","journal-title":"Acta Vet Scand"},{"issue":"1","key":"4974_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-2885.2007.00927.x","volume":"31","author":"P Mar\u00edn","year":"2008","unstructured":"Mar\u00edn P, Fern\u00e1ndez-Var\u00f3n E, Escudero E, Vancraeynest D, C\u00e1rceles CM. Pharmacokinetic-pharmacodynamic integration of Orbifloxacin in rabbits after intravenous, subcutaneous and intramuscular administration. J Vet Pharmacol Ther. 2008;31(1):77\u201382.","journal-title":"J Vet Pharmacol Ther"},{"issue":"5","key":"4974_CR9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/00071668.2011.616953","volume":"52","author":"MA Tohamy","year":"2011","unstructured":"Tohamy MA. Comparative pharmacokinetics of orbifloxacin in healthy and Pasteurella multocida infected ducks. Br Poult Sci. 2011;52(5):639\u201344.","journal-title":"Br Poult Sci"},{"issue":"3","key":"4974_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1292\/jvms.21-0517","volume":"84","author":"T Kuramae","year":"2022","unstructured":"Kuramae T, Ishikawa S, Kono A, Hobo S. Pharmacokinetics in plasma and alveolar regions of a healthy calf intramuscularly administered a single dose of orbifloxacin. J Vet Med Sci. 2022;84(3):400\u20135.","journal-title":"J Vet Med Sci"},{"issue":"3","key":"4974_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1365-2885.2006.00737.x","volume":"29","author":"JL Davis","year":"2006","unstructured":"Davis JL, Papich MG, Weingarten A. The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration. J Vet Pharmacol Ther. 2006;29(3):191\u20137.","journal-title":"J Vet Pharmacol Ther"},{"issue":"9","key":"4974_CR12","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.3168\/jds.2007-0071","volume":"90","author":"P Mar\u00edn","year":"2007","unstructured":"Mar\u00edn P, Escudero E, Fern\u00e1ndez-Var\u00f3n E, C\u00e1rceles CM. Pharmacokinetics and milk penetration of orbifloxacin after intravenous, subcutaneous, and intramuscular administration to lactating goats. J Dairy Sci. 2007;90(9):4219\u201325.","journal-title":"J Dairy Sci"},{"issue":"3","key":"4974_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1365-2885.2008.00954.x","volume":"31","author":"A Goudah","year":"2008","unstructured":"Goudah A, Abo-El-Sooud K. Pharmacokinetics and milk penetration of Orbifloxacin after intravenous and intramuscular injections to dromedary lactating camels (Camelus dromedarius). J Vet Pharmacol Ther. 2008;31(3):276\u201380.","journal-title":"J Vet Pharmacol Ther"},{"issue":"6","key":"4974_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2885.2004.00603.x","volume":"27","author":"QA McKellar","year":"2004","unstructured":"McKellar QA, Sanchez Bruni SF, Jones DG. Pharmacokinetic\/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. J Vet Pharmacol Ther. 2004;27(6):503\u201314.","journal-title":"J Vet Pharmacol Ther"},{"issue":"5","key":"4974_CR15","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/infdis\/147.5.910","volume":"147","author":"AU Gerber","year":"1983","unstructured":"Gerber AU, Craig WA, Brugger HP, Feller C, Vastola AP, Brandel J. Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice. J Infect Dis. 1983;147(5):910\u20137.","journal-title":"J Infect Dis"},{"issue":"1","key":"4974_CR16","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1038\/s41467-022-29234-3","volume":"13","author":"KD Roberts","year":"2022","unstructured":"Roberts KD, Zhu Y, Azad MAK, Han ML, Wang J, Wang L, Yu HH, Horne AS, Pinson JA, Rudd D, et al. A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens. Nat Commun. 2022;13(1):1625.","journal-title":"Nat Commun"},{"issue":"5","key":"4974_CR17","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.4142\/jvs.2019.20.e40","volume":"20","author":"W Luo","year":"2019","unstructured":"Luo W, Chen D, Wu M, Li Z, Tao Y, Liu Q, Pan Y, Qu W, Yuan Z, Xie S. Pharmacokinetics\/pharmacodynamics models of veterinary antimicrobial agents. J Vet Sci. 2019;20(5):e40.","journal-title":"J Vet Sci"},{"issue":"4","key":"4974_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2885.2010.01233.x","volume":"34","author":"MG Hawkins","year":"2011","unstructured":"Hawkins MG, Taylor IT, Byrne BA, Armstrong RD, Tell LA. Pharmacokinetic-pharmacodynamic integration of Orbifloxacin in Japanese quail (Coturnix japonica) following oral and intravenous administration. J Vet Pharmacol Ther. 2011;34(4):350\u20138.","journal-title":"J Vet Pharmacol Ther"},{"issue":"7","key":"4974_CR19","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1128\/AAC.01346-08","volume":"53","author":"E Gebru","year":"2009","unstructured":"Gebru E, Lee JS, Chang ZQ, Hwang MH, Cheng H, Park SC. Integration of pharmacokinetic and pharmacodynamic indices of Orbifloxacin in beagle dogs after a single intravenous and intramuscular administration. Antimicrob Agents Chemother. 2009;53(7):3024\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"4974_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1365-2885.2008.01027.x","volume":"32","author":"G Elias","year":"2009","unstructured":"Elias G, Lee JS, Hwang MH, Park YS, Cho KH, Kim YH, Park SC. Pharmacokinetics and pharmacokinetic\/pharmacodynamic integration of Orbifloxacin in Korean Hanwoo cattle. J Vet Pharmacol Ther. 2009;32(3):219\u201328.","journal-title":"J Vet Pharmacol Ther"},{"issue":"4","key":"4974_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1023\/B:VERC.0000048503.05426.68","volume":"29","author":"AM Abd El-Aty","year":"2005","unstructured":"Abd El-Aty AM, Goudah A, Ismail M, Shimoda M. Disposition kinetics of Difloxacin in rabbit after intravenous and intramuscular injection of dicural. Vet Res Commun. 2005;29(4):297\u2013304.","journal-title":"Vet Res Commun"},{"issue":"4","key":"4974_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1365-2885.2005.00665.x","volume":"28","author":"E Fern\u00e1ndez-Var\u00f3n","year":"2005","unstructured":"Fern\u00e1ndez-Var\u00f3n E, Bovaira MJ, Espuny A, Escudero E, Vancraeynest D, C\u00e1rceles CM. Pharmacokinetic-pharmacodynamic integration of Moxifloxacin in rabbits after intravenous, intramuscular and oral administration. J Vet Pharmacol Ther. 2005;28(4):343\u20138.","journal-title":"J Vet Pharmacol Ther"},{"issue":"2","key":"4974_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1472-765X.2011.03090.x","volume":"53","author":"A Filocamo","year":"2011","unstructured":"Filocamo A, Bisignano C, D\u2019Arrigo M, Ginestra G, Mandalari G, Galati EM. Norfloxacin and ursolic acid: in vitro association and postantibiotic effect against Staphylococcus aureus. Lett Appl Microbiol. 2011;53(2):193\u20137.","journal-title":"Lett Appl Microbiol"},{"issue":"1","key":"4974_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/jac\/dki163","volume":"56","author":"S Mizunaga","year":"2005","unstructured":"Mizunaga S, Kamiyama T, Fukuda Y, Takahata M, Mitsuyama J. Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems. J Antimicrob Chemother. 2005;56(1):91\u20136.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"4974_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/516284","volume":"26","author":"WA Craig","year":"1998","unstructured":"Craig WA. Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26(1):1\u201310. quiz 11\u201312.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4974_CR26","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1128\/AAC.41.5.950","volume":"41","author":"L Licata","year":"1997","unstructured":"Licata L, Smith CE, Goldschmidt RM, Barrett JF, Frosco M. Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae. Antimicrob Agents Chemother. 1997;41(5):950\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"4974_CR27","doi-asserted-by":"publisher","first-page":"e01354","DOI":"10.1128\/AAC.01354-20","volume":"64","author":"YF Zhou","year":"2020","unstructured":"Zhou YF, Liu P, Dai SH, Sun J, Liu YH, Liao XP. In vivo pharmacodynamic target assessment of Antofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in a neutropenic murine pneumonia model. Antimicrob Agents Chemother. 2020;64(12):e01354-20.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7 Suppl Contemp","key":"4974_CR28","first-page":"17","volume":"108","author":"MD Reed","year":"2000","unstructured":"Reed MD. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface. Postgrad Med. 2000;108(7 Suppl Contemporaty):17\u201324.","journal-title":"Postgrad Med"},{"issue":"4","key":"4974_CR29","doi-asserted-by":"publisher","first-page":"E38","DOI":"10.1208\/ps040438","volume":"4","author":"PL Toutain","year":"2002","unstructured":"Toutain PL. Pharmacokinetic\/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine. AAPS PharmSci. 2002;4(4):E38.","journal-title":"AAPS PharmSci"},{"issue":"6","key":"4974_CR30","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1128\/AAC.46.6.1665-1670.2002","volume":"46","author":"D Andes","year":"2002","unstructured":"Andes D, Craig WA. Pharmacodynamics of the new fluoroquinolone Gatifloxacin in murine thigh and lung infection models. Antimicrob Agents Chemother. 2002;46(6):1665\u201370.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 3","key":"4974_CR31","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1086\/321841","volume":"33","author":"X Zhao","year":"2001","unstructured":"Zhao X, Drlica K. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin Infect Dis. 2001;33(Suppl 3):S147\u2013156.","journal-title":"Clin Infect Dis"},{"key":"4974_CR32","unstructured":"CLSI. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals. CLSl document VET01S Clinical and Laboratory Standards Institute. Wayne. 2020."},{"key":"4974_CR33","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.phrs.2017.11.010","volume":"129","author":"R Shang","year":"2018","unstructured":"Shang R, Yi Y, Zhang C, Fu Y, Liang J, Pu W. Antibacterial activity and pharmacokinetic profile of a promising antibacterial agent: 14-O-[(4-amino-6-hydroxy-pyrimidine-2-yl)thioacetyl] mutilin. Pharmacol Res. 2018;129:424\u201331.","journal-title":"Pharmacol Res"},{"issue":"4","key":"4974_CR34","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1590\/S1517-83822009000400033","volume":"40","author":"L Wang","year":"2009","unstructured":"Wang L, Zhang Y. Postantibiotic effects and postantibiotic sub-MIC effects of tilmicosin, erythromycin and tiamulin on erythromycin-resistant Streptococcus suis. Braz J Microbiol. 2009;40(4):980\u20137.","journal-title":"Braz J Microbiol"},{"issue":"3","key":"4974_CR35","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/02652030802484851","volume":"26","author":"YL Li","year":"2009","unstructured":"Li YL, Hao XL, Ji BQ, Xu CL, Chen W, Shen CY, Ding T. Rapid determination of 19 quinolone residues in spiked fish and pig muscle by high-performance liquid chromatography (HPLC) tandem mass spectrometry. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2009;26(3):306\u201313.","journal-title":"Food Addit Contam Part A Chem Anal Control Expo Risk Assess"},{"issue":"1","key":"4974_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0021-9673(02)01407-3","volume":"982","author":"L Johnston","year":"2002","unstructured":"Johnston L, Mackay L, Croft M. Determination of quinolones and fluoroquinolones in fish tissue and seafood by high-performance liquid chromatography with electrospray ionisation tandem mass spectrometric detection. J Chromatogr A. 2002;982(1):97\u2013109.","journal-title":"J Chromatogr A"},{"issue":"3","key":"4974_CR37","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1124\/pr.111.005769","volume":"65","author":"EI Nielsen","year":"2013","unstructured":"Nielsen EI, Friberg LE. Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs. Pharmacol Rev. 2013;65(3):1053\u201390.","journal-title":"Pharmacol Rev"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-04974-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-025-04974-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-04974-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:53:17Z","timestamp":1757451197000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-025-04974-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4974"],"URL":"https:\/\/doi.org\/10.1186\/s12917-025-04974-8","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All mice were housed and handled in accordance with the National Standards for Laboratory Animals of China (GB 14925\u2009\u2212\u20092010). The experimental protocol was approved by Institutional Animal Care and Use Committee (IACUC) of South China Agricultural University, Approval No. 2020C047.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"531"}}